MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032782 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bianka Gurbi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Ministry of Innovation and Technology of Hungary; National Research, Development and Innovation Fund, NKFI Fund of National Research, Development and Innovation Office.
Abstract (Originalsprache)
The poor prognosis of head-and-neck squamous cell carcinoma (HNSCC) is partly due to the lack of reliable prognostic and predictive markers. The Ras/Raf/MEK/ERK signaling pathway is often activated by overexpressed epidermal growth factor receptor (EGFR) and stimulates the progression of HNSCCs. Our research was performed on three human papillomavirus (HPV)-negative HNSCC-cell lines: Detroit 562, FaDu and SCC25. Changes in cell viability upon EGFR and/or MEK inhibitors were measured by the MTT method. The protein-expression and phosphorylation profiles of the EGFR-initiated signaling pathways were assessed using Western-blot analysis. The EGFR expression and pY1068-EGFR levels were also studied in the patient-derived HNSCC samples. We found significant differences between the sensitivity of the tumor-cell lines used. The SCC25 line was found to be the most sensitive to the MEK inhibitors, possibly due to the lack of feedback Akt activation through EGFR. By contrast, this feedback activation had an important role in the FaDu cells. The observed insensitivity of the Detroit 562 cells to the MEK inhibitors might have been caused by their PIK3CA mutation. Among HNSCC cell lines, EGFR-initiated signaling pathways are particularly versatile. An ERK/EGFR feedback loop can lead to Akt-pathway activation upon MEK inhibition, and it is related not only to increased amounts of EGFR but also to the elevation of pY1068-EGFR levels. The presence of this mechanism may justify the combined application of EGFR and MEK inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Semmelweis University, H-1094 Budapest, Hungary.
- MTA-SE Pathobiochemistry Research Group, Semmelweis University, H-1094 Budapest, Hungary.
- Department of Pathology and Experimental Cancer Research, Semmelweis University, H-1085 Budapest, Hungary.
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Semmelweis University, H-1083 Budapest, Hungary.
- Department of Voice, Speech and Swallowing Therapy, Faculty of Health Sciences, Semmelweis University, H-1088 Budapest, Hungary.
ORCID-Profile: Bianka Gurbi, Diána Brauswetter, Tibor Krenács, Kornél Dános, Miklós Csala
Förderung
- National Research, Development and Innovation Office
- Ministry of Innovation and Technology of Hungary; National Research, Development and Innovation Fund
- NKFI Fund of National Research, Development and Innovation Office
- TKP2021-EGA funding scheme
Zitieren
APA
Gurbi, B., Brauswetter, D., Pénzes, K., Varga, A., Krenács, T., Dános, K., Birtalan, E., Tamás, L., & Csala, M. (2023). MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032782
Vancouver
Gurbi B, Brauswetter D, Pénzes K, Varga A, Krenács T, Dános K, et al. MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032782
BibTeX
@article{Gurbi2023,
author = {Gurbi, Bianka and Brauswetter, Diána and Pénzes, Kinga and Varga, Attila and Krenács, Tibor and Dános, Kornél and Birtalan, Ede and Tamás, László and Csala, Miklós},
title = {MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032782}
}
EUVIMED